Literature DB >> 8810672

Prevalence of self-reported depression in patients with rheumatoid arthritis.

T Pincus1, J Griffith, S Pearce, D Isenberg.   

Abstract

The prevalence of self-reported depressive symptoms was investigated in a case-control study of patients with rheumatoid arthritis (RA) attending an out-patient clinic at the Middlesex Hospital. Patients selected their own controls, matched for age and sex. Previous attempts to measure depressive symptoms in RA have suffered from measurement error due to criterion contamination, where psychological symptoms augment depressive scores. A total of 163 patients (77% of the sample) and 115 matched pairs completed the Hospital Anxiety and Depression Scale (HADS). The results indicated that RA patients are more depressed and anxious than controls. The prevalence of depression above the cut-point was 15%. This figure is comparable to other reports adjusted for criterion contamination, but is lower than that of other studies which employ 'contaminated' tools. The depression scale of the HADS appeared to be relatively free of criterion contamination. Subject to further reliability testing, the HADS may be a practical screening tool for practitioners to assess patients in need of psychological interventions.

Entities:  

Mesh:

Year:  1996        PMID: 8810672     DOI: 10.1093/rheumatology/35.9.879

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  31 in total

1.  Diagnosis and treatment of mood disorders in patients with rheumatic disease.

Authors:  M Alpay; E H Cassem
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

2.  Suicidal ideation in patients with rheumatoid arthritis. Research may help identify patients at high risk.

Authors:  G J Treharne; A C Lyons; G D Kitas
Journal:  BMJ       Date:  2000-11-18

3.  The relationship between disease activity and depressive symptoms severity and optimism--results from the IMPROVED study.

Authors:  L Heimans; K V C Wevers-de Boer; K Visser; H K Ronday; G M Steup-Beekman; M van Oosterhout; T W J Huizinga; E J Giltay; R C van der Mast; C F Allaart
Journal:  Clin Rheumatol       Date:  2013-07-24       Impact factor: 2.980

4.  Prevalence of anxiety and depression in osteoarthritis: use of the Hospital Anxiety and Depression Scale as a screening tool.

Authors:  John Axford; Alexander Butt; Christine Heron; John Hammond; John Morgan; Azita Alavi; Jim Bolton; Martin Bland
Journal:  Clin Rheumatol       Date:  2010-08-19       Impact factor: 2.980

5.  Differential Association of Psychosocial Comorbidities With Subclinical Atherosclerosis in Rheumatoid Arthritis.

Authors:  Ying L Liu; Moyses Szklo; Karina W Davidson; Joan M Bathon; Jon T Giles
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-10       Impact factor: 4.794

6.  Depression in patients with rheumatoid arthritis: description, causes and mechanisms.

Authors:  Mary Margaretten; Laura Julian; Patricia Katz; Edward Yelin
Journal:  Int J Clin Rheumtol       Date:  2011

7.  Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA.

Authors:  E Aurrecoechea; J Llorca Díaz; M L Diez Lizuain; G McGwin; J Calvo-Alen
Journal:  Rheumatol Int       Date:  2016-12-16       Impact factor: 2.631

8.  Anxiety and depression in rheumatoid arthritis: an epidemiologic survey and investigation of clinical correlates in Iranian population.

Authors:  Ahmad-Reza Jamshidi; Arash Tehrani Banihashemi; Pedram Paragomi; Maryam Hasanzadeh; Mozhgan Barghamdi; Shima Ghoroghi
Journal:  Rheumatol Int       Date:  2016-05-18       Impact factor: 2.631

9.  Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis.

Authors:  M Margaretten; E Yelin; J Imboden; J Graf; J Barton; P Katz; L Julian
Journal:  Arthritis Rheum       Date:  2009-11-15

10.  The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study.

Authors:  Yvonne C Lee; Lori B Chibnik; Bing Lu; Ajay D Wasan; Robert R Edwards; Anne H Fossel; Simon M Helfgott; Daniel H Solomon; Daniel J Clauw; Elizabeth W Karlson
Journal:  Arthritis Res Ther       Date:  2009-10-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.